Clinical Trial

Efficacy and Safety of Skincare Serum and Cream for Anti-aging of Facial Skin

Not Yet Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated October 15, 2024 (before its estimated March 5, 2025 completion). Its status may not reflect the trial's current state.
Summary
The primary objective of this study is to assess the efficacy and safety of combination therapy of BABOR® Ultimate ECM Repair Serum and the BABOR® Cure Cream for the improvement of anti-aging through the use of investigator assessments, subject questionnaires/assessments, photography, skin imaging, and reported adverse reactions.
Trial Details
NCT Number NCT06638905
Lead Sponsor Goldman, Butterwick, Fitzpatrick and Groff
Collaborators: Babor Americas
Conditions Facial Wrinkles, Skin Aging
Enrollment 18 participants
Start Date 2024-10-28
Primary Completion 2025-03-05 (estimated)
Study Completion 2025-05-05 (estimated)
Updated on ClinicalTrials.gov 2024-10-15